The growing problem of antibiotic resistance in clinically relevant Gram-negative bacteria: current situation

被引:23
|
作者
Martinez-Martinez, Luis [1 ]
Calvo, Jorge [1 ]
机构
[1] Hosp Univ Marques Valdecilla, Microbiol Serv, Santander, Spain
关键词
Enterobacteria; Multiresistance; beta-lactamases; Carbapenems; Pseudomonas aeruginosa; Acinetobacter baumannii;
D O I
10.1016/S0213-005X(10)70027-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Resistance to antimicrobial agents in clinically relevant Gram-negative bacteria is an increasingly important problem, which in the last few years has spread from the hospital setting to the community. In enterobacteria, the main features of this situation include resistance to beta-lactams and quinolones. beta-Lactam resistance is caused by intrinsic beta-lactamases, extended-spectrum beta-lactamases, plasmid-mediated cephamycinases and carbapenemses, particularly when produced in strains with decreased permeability because of altered porin expression. Quinolone resistance is a multifactorial problem in which the importance of plasmid-mediated mechanisms (Qnr proteins, acetylase, active efflux pumps) is being recognized. Several studies in Spain and other countries show that strains with these resistance mechanisms are being isolated with increased frequency. Of particular concern is the spread of Escherichia coli and other species producing extended-spectrum beta-lactamases (most frequently of the CTX-M family), affecting outpatients. Very commonly these mechanisms are simultaneously expressed within the same bacterial host, leading to a multiresistance phenotype. This problem is also of major clinical importance in non-fermenting Gram-negative rods, including Pseudomonas aeruginosa and Acinetobacter baumannii and, to a lesser extent, Stenotrophomonas maltophilia and some other species. Multiresistance in non-fermenting organisms results from the presence of intrinsic mechanisms (production of distinct beta-lactamases, decreased permeability and expression of several active efflux pumps) and from the acquisition of exogenous genes. Therapeutic difficulties reach their maximum when bacteria express resistance to carbapenems (a multifactorial problem) or to polymyxins. New compounds with specific activity against multiresistant Gram-negative rods should be developed, which, together with other measures, would contribute to controlling the current serious situation. (c) 2010 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 50 条
  • [1] Evaluation of Antibiotic Resistance Mechanisms in Gram-Negative Bacteria
    Gauba, Anusha
    Rahman, Khondaker Miraz
    ANTIBIOTICS-BASEL, 2023, 12 (11):
  • [2] EPIDEMIOLOGY OF ANTIBIOTIC-RESISTANCE IN GRAM-NEGATIVE BACTERIA
    WILLIAMS, RJ
    JOURNAL OF HOSPITAL INFECTION, 1988, 11 : 130 - 134
  • [3] Analysis of antibiotic resistance regions in Gram-negative bacteria
    Partridge, Sally R.
    FEMS MICROBIOLOGY REVIEWS, 2011, 35 (05) : 820 - 855
  • [4] Polymicrobial infections involving clinically relevant Gram-negative bacteria and fungi
    Dhamgaye, Sanjiveeni
    Qu, Yue
    Peleg, Anton Y.
    CELLULAR MICROBIOLOGY, 2016, 18 (12) : 1716 - 1722
  • [5] Current Epidemiology and Growing Resistance of Gram-Negative Pathogens
    Livermore, David M.
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2012, 27 (02): : 128 - 142
  • [6] Navigating Antibiotic Resistance in Gram-Negative Bacteria: Current Challenges and Emerging Therapeutic Strategies
    Kumari, Reshma
    Saraogi, Ishu
    CHEMPHYSCHEM, 2025,
  • [7] Current concepts in antibiotic-resistant Gram-negative bacteria
    Torres, Julian Andres
    Villegas, Maria Virginia
    Quinn, Andjohn P.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2007, 5 (05) : 833 - 843
  • [8] Antibiotic resistance of gram-negative bacteria in rivers, United States
    Ash, RJ
    Mauck, B
    Morgan, M
    EMERGING INFECTIOUS DISEASES, 2002, 8 (07) : 713 - 716
  • [9] Anaerobic Gram-Negative Bacteria: Role as a Reservoir of Antibiotic Resistance
    Sood, Anshul
    Ray, Pallab
    Angrup, Archana
    ANTIBIOTICS-BASEL, 2023, 12 (05):
  • [10] Glycopeptide Antibiotic To Overcome the Intrinsic Resistance of Gram-Negative Bacteria
    Yarlagadda, Venkateswarlu
    Manjunath, Goutham B.
    Sarkar, Paramita
    Akkapeddi, Padma
    Paramanandham, Krishnamoorthy
    Shome, Bibek R.
    Ravikumar, Raju
    Haldar, Jayanta
    ACS INFECTIOUS DISEASES, 2016, 2 (02): : 132 - 139